HPRP-A1

General Information


DCTPep ID  DCTPep00858

Peptide Name   HPRP-A1

Sequence  FKKLKKLFSKLWNWK

Sequence Length  15

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

ACP Tumor active peptide



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
NCI-H460 Lung large cell carcinoma IC50=13.3 µM MTT assay 24h 1
BGC-823 Human papillomavirus-related endocervical adenocarcinoma IC50=14.1 µM MTT assay 24h 1
A549 Lung adenocarcinoma IC50=14.8 µM MTT assay 24h 1
MCF-7 Invasive breast carcinoma of no special type IC50=15.7 µM MTT assay 24h 1
MDA-MB-231 Breast adenocarcinoma IC50=22.9 µM MTT assay 24h 1

Hemolytic Activity  Human red blood cells: MHC=32 μM, MHC: the minimum hemolytic concentration is the concentration of peptide that results in 10% hemolysis of human red blood cells (hRBCs).

Normal (non-cancerous) Cytotoxicity  HUVEC: IC50=24.2 μM

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  DCTPep00858

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C101H156N24O18

Absent amino acids  ACDEGHIMPQRTVY

Theoretical pI  10.70

Acidic residues  0

Basic residues  6

Polar residues  2

Molecular weight (Average)  1994.5

Molecular weight (Monoisotopic)  1993.2

Common amino acids  K

Net charge  6

Instability index (II)  -6.23

Aliphatic index  78.00

Grand average of hydropathicity (GRAVY)  -0.833

Half Life 
  1.1 hours (mammalian reticulocytes, in vitro).
  3 min (yeast, in vivo).
  2 min (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 11000
  Abs 0.1% (=1 g/l) 5.515

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30592418

Title  Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation

Doi 10.1021/acs.molpharmaceut.8b00854

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.